Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

Left Ventricular Assist Device under Chronic Kidney Disease: Cautious, But We Still Need More Details

Lee SY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rationale and Study Design of the Withdrawal of Spironolactone for Heart Failure with Improved Left Ventricular Ejection Fraction

Hyun J, Lee SE, Lee SA, Hong JA, Kim MS, Kim JJ

It is unclear if guideline-directed medical therapy (GDMT) should be maintained in patients who have heart failure (HF) with improved ejection fraction (HFiEF). Of the medications recommended for HF, mineralocorticoid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Endurance Exercise Training Prevents Elevation of Soluble ST2 in Mice with Doxorubicin-Induced Myocardial Injury

Kim BJ, Choi JY, Oh SJ, Heo JH

Background and Objectives: Endurance exercise training (ET) can improve outcomes for patients with heart failure (HF). We investigated the preventive effects of ET on serum biomarkers for HF in mice...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Remote Patient Monitoring in Heart Failure: Factors for Clinical Efficacy

Bhatia A, Maddox TM

Despite clinical advances in its treatment, heart failure (HF) is associated with significant adverse clinical outcomes and is among the greatest drivers of healthcare utilization. Outpatient management of HF remains suboptimal,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of Renal Dysfunction on Outcomes after Left Ventricular Assist Device: A Systematic Review

Ibrahim M, Saint Croix GR, Lacy S, Chaparro S

Background and Objectives: Renal dysfunction is a common comorbidity in patients with advanced heart failure who may benefit from left ventricular assist device (LVAD) therapy.The effect of preoperative renal dysfunction...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center

Chang DH, Youn JC, Dilibero D, Patel JK, Kobashigawa JA

Heart transplant is the optimal treatment for selected patients with end-stage heart failure. Immunosuppression after heart transplantation has significantly reduced the incidence of rejection and improved patient outcomes with the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cardiac Rehabilitation in Heart Failure

Chun Kh, Kang SM

Heart failure (HF) is a complex clinical syndrome caused by a structural and/or functional cardiac abnormality, resulting in reduced organ perfusion. The goals of treatment in patients with HF are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr